Cutaneous lymphoproliferative disorders research

Cutaneous lymphoproliferative disorders are a heterogeneous group of malignancies in which lymphocytes proliferate abnormally within the skin, with mycosis fungoides and Sézary syndrome representing the most common and well-characterized subtypes of primary cutaneous T-cell lymphoma. Researchers in this area work to refine classification systems such as the WHO-EORTC framework, improve staging accuracy, identify molecular and genomic markers that predict disease progression, and evaluate therapies ranging from retinoids like bexarotene to targeted biological agents. Because early-stage disease can mimic benign inflammatory conditions for years before diagnosis, understanding the genomic landscape and identifying reliable biomarkers remains a pressing challenge. Active directions include characterizing the clonal evolution of CD30+ lymphoproliferative disorders, optimizing treatment sequencing for refractory disease, and translating molecular profiling into more personalized prognostic and therapeutic strategies.

Works

42,604

Total citations

432,528

Keywords

Cutaneous LymphomasMycosis FungoidesSézary SyndromeEORTC ClassificationT-Cell LymphomaCD30+ Lymphoproliferative Disorders